DYRK1A and hepatocellular carcinoma: Meanwhile, combination treatment with DYRK1 blocking and chemotherapeutic drug effectively inhibited the growth of TROAP-overexpressed HCC cells in mouse, which presented a novel therapeutic approach in HCC.